3,5-PYRIDINEDICARBOXYLIC ACID, 4-(2,3-DICHLOROPHENYL)-1,4-DIHYDRO-2,6-DIMETHYL-, 3-METHYL 5-[(1-OXOBUTOXY)METHYL] ESTER, 97%, 25g

5-Bromo-3-methoxy-2-methylpyridine, 95.0%, 250mg

5-BROMOOXAZOLE HYDROCHLORIDE, 95%, 100mg

1-Methyl-3-n-octylimidazolium Hexafluorophosphate, 98%, 5g

1-Bromo-3-fluoro-2-methyl-5-nitrobenzene, 97%, 250mg

2-(2-Furanyl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane, 95.0%, 10g

(R)-(-)-DBD-APy [=(R)-(-)-4-(N,N-Dimethylaminosulfonyl)-7-(3-aminopyrrolidin-1-yl)-2,1,3-benzoxadiazole] [HPLC Labeling Reagent for e.e. Determination]>98.0%(HPLC)100mg

3-CHLORO-4-METHYL-THIOPHENE-2-CARBALDEHYDE, 95.0%, 1g

4-CHLORO-5,6-DIMETHYL-7H-PYRROLO[2,3-D]PYRIMIDINE, 95.0%, 250mg

3-Methyl-1-phenyl-1H-pyrazole, 95.0%, 5g

methyl 4-isothiocyanatobutanoate, 95.0%, 10g

2-(PYRROLIDIN-1-YL)-5,6,7,8-TETRAHYDROPYRIDO[4,3-D]PYRIMIDINE, 97.0%, 1g

(R)-1-(3-Methylbenzyl)pyrrolidin-3-amine dihydrochloride, 1g